July 28 - Virtual Workshops
Morning Session
10:00-11:00 (Tokyo)
09:00-10:00 (Shanghai)
Antibody Modeling and Protein Engineering 
Protein Engineering / Protein Properties / Developability / Hot Spot Analysis / Antibody Modeling / Humanization / Molecular Surfaces
Delivered in English, Chinese, Japanese
11:00-11:15 (Tokyo)
10:00-10:15 (Shanghai)
Morning Break
11:15-12:15 (Tokyo)
10:15-11:15 (Shanghai)
Biologics: Protein Alignments, Modeling and Docking 
Protein Alignments and Superposition / Loop and Linker Modeling / Homology Modeling / Protein- Protein Docking
Delivered in English, Chinese, Japanese
July 28 - Scientific Presentations     Delivered in English
Afternoon Session
13:30-13:40 (Tokyo)
12:30-12:40 (Shanghai)
Opening Remarks
13:40-14:10 (Tokyo)
12:40-13:10 (Shanghai)
An Introduction to Biopharmaceutical Informatics 
Sandeep Kumar, Distinguished Research Fellow (Biotherapeutics) and Group Leader, Boehringer Ingelheim (US)
14:10-14:40 (Tokyo)
13:10-13:40 (Shanghai)
Recent Progress in the Development of FMODB: A Database of QM-based Interaction Data of Biomolecules for Drug Discovery and Protein Functional Analysis 
Daisuke Takaya, Specially Appointed Associate Professor, Quantum life science and bioinformatics, Osaka University
14:40-15:10 (Tokyo)
13:40-14:10 (Shanghai)
Target Proteins and Mode of Actions of Bioactive Marine Natural Products 
Masaki Kita, Professor, Grad. Sch. of Bioagricultural Sciences, Nagoya University (JP)
15:10-15:40 (Tokyo)
14:10-14:40 (Shanghai)
Computational Approaches for Optimizing the Developability of Biotherapeutics 
Andrew Henry, Principal Scientist, Chemical Computing Group (UK)
15:40-15:50 (Tokyo)
14:40-14:50 (Shanghai)
Afternoon Break
15:50-16:20 (Tokyo)
14:50-15:20 (Shanghai)
Structure Analysis of RNA Viruses by Computational Science 
Masaru Yokoyama, Senior Research Scientist, National Institute of Infectious Diseases (JP)
16:20-16:50 (Tokyo)
15:20-15:50 (Shanghai)
Enhanced Sampling for Antibody Affinity Maturation 
Yue Qian, Senior Director, Viva Biotech (Shanghai) Ltd. (CN)
16:50-17:20 (Tokyo)
15:50-16:20 (Shanghai)
Computational Profiling of Pharmacokinetics for Multi-specific Antibodies 
Pep Amengual-Rigo, Senior Data Scientist, Sanofi (DE)
17:20-17:50 (Tokyo)
16:20-16:50 (Shanghai)
Post-antibody Drugs: Generation of a Novel Class of Drug Modalities Based on Molecular-Targeting Helix-Loop-Helix (HLH) Peptides 
Ikuo Fujii, Professor, Dept. of Biological Sciences, Osaka Prefecture University (JP)
17:50-18:00 (Tokyo)
16:50-17:00 (Shanghai)
Closing Remarks